Delivery Order SPE2DB22D1106-SPE2DB25FDPM9

Award Date 12/6/24
Potential Completion Date 12/9/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDPM9
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDPM9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,264.59, is for the delivery of Eliquis 5 mg tablets.

The award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen is the prime contractor for this award, and the company's extensive supply chain and distribution capabilities make it a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This contract award demonstrates the company's role in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical products, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 3/7/25, 10:12 AM